Page last updated: 2024-08-23

acetylgalactosamine and Carcinoma, Pancreatic Ductal

acetylgalactosamine has been researched along with Carcinoma, Pancreatic Ductal in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kokudo, N; Tang, W; Xu, HL; Zhang, KM; Zhao, X	1

Other Studies

1 other study(ies) available for acetylgalactosamine and Carcinoma, Pancreatic Ductal

Article	Year
Inhibition of KL-6/MUC1 glycosylation limits aggressive progression of pancreatic cancer. World journal of gastroenterology, 2014, Sep-14, Volume: 20, Issue:34 Topics: Acetylgalactosamine; Adenocarcinoma, Papillary; Adult; Aged; Aged, 80 and over; Antigens, CD; Antineoplastic Agents; Benzyl Compounds; Biomarkers, Tumor; Cadherins; Carcinoma, Pancreatic Ductal; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Progression; Dose-Response Relationship, Drug; Enzyme Inhibitors; Epithelial-Mesenchymal Transition; Female; Glycosylation; Humans; Male; Middle Aged; Mucin-1; Neoplasm Invasiveness; Neoplasms, Cystic, Mucinous, and Serous; Pancreatic Neoplasms; Time Factors; Tunicamycin; Vimentin	2014

Article

Year

Inhibition of KL-6/MUC1 glycosylation limits aggressive progression of pancreatic cancer.

World journal of gastroenterology, 2014, Sep-14, Volume: 20, Issue:34

Topics: Acetylgalactosamine; Adenocarcinoma, Papillary; Adult; Aged; Aged, 80 and over; Antigens, CD; Antineoplastic Agents; Benzyl Compounds; Biomarkers, Tumor; Cadherins; Carcinoma, Pancreatic Ductal; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Progression; Dose-Response Relationship, Drug; Enzyme Inhibitors; Epithelial-Mesenchymal Transition; Female; Glycosylation; Humans; Male; Middle Aged; Mucin-1; Neoplasm Invasiveness; Neoplasms, Cystic, Mucinous, and Serous; Pancreatic Neoplasms; Time Factors; Tunicamycin; Vimentin

2014